Organic Letters
Letter
limited accessibility of difluorobenzyl chlorides.8h Indeed,
heating difluorobenzyl chloride 7a possessing a bulky bromo
group at the ortho position with phenol in the presence of
cesium carbonate in DMSO furnished difluorobenzyl ether 12a
in high yield, and no side product formed by C−F cleavage was
observed.18 Difluorobenzyl ethers 12b and 12c were also
prepared from 4- and 2-methoxyphenol, respectively. We also
succeeded in the synthesis of difluorobenzyl ether 12d in
moderate yield leaving the ester moiety untouched. It is
noteworthy that O-benzylation proceeded selectively to
provide 12e when difluorobenzyl chloride 7a was treated
with 2-pyridone, and the N-benzylation product was not
detected. Unfortunately, cyclohexyl difluorobenzyl ether 12f
was not detected in the reaction of 7a with cyclohexanol.
Furthermore, various difluorobenzyl chlorides participated in
the difluorobenzyl ether synthesis. For instance, 4-methox-
yphenyl-substituted difluorobenzyl ether 12g was efficiently
synthesized by O-benzylation of phenol. In addition,
methoxycarbonyl-substituted difluorobenzyl ether 12h was
prepared, albeit in low yield. O-Benzylation of phenol allowed
for the preparation of difluorobenzyl ethers 12i and 12j
possessing heteroaromatic rings. We also accomplished the
synthesis of electron-deficient difluorobenzyl ethers 12k−m
having bromo- and trifluoromethyl groups. The difluorobenzyl
ether synthesis would be useful in pharmaceutical sciences and
agrochemistry since a broad range of benzyl ethers are
bioactive compounds and replacing hydrogen atoms with
fluorines has gained attention as a means to modulate the
properties such as bioactivity, lipophilicity, and stability toward
oxidation.
AUTHOR INFORMATION
Corresponding Author
■
Suguru Yoshida − Laboratory of Chemical Bioscience,
Institute of Biomaterials and Bioengineering, Tokyo Medical
and Dental University (TMDU), Chiyoda-ku, Tokyo 101-
Authors
Rika Idogawa − Laboratory of Chemical Bioscience, Institute
of Biomaterials and Bioengineering, Tokyo Medical and
Dental University (TMDU), Chiyoda-ku, Tokyo 101-0062,
Japan
Youngchan Kim − Laboratory of Chemical Bioscience,
Institute of Biomaterials and Bioengineering, Tokyo Medical
and Dental University (TMDU), Chiyoda-ku, Tokyo 101-
0062, Japan
Ken Shimomori − Laboratory of Chemical Bioscience,
Institute of Biomaterials and Bioengineering, Tokyo Medical
and Dental University (TMDU), Chiyoda-ku, Tokyo 101-
0062, Japan
Takamitsu Hosoya − Laboratory of Chemical Bioscience,
Institute of Biomaterials and Bioengineering, Tokyo Medical
and Dental University (TMDU), Chiyoda-ku, Tokyo 101-
Complete contact information is available at:
Notes
Samarium-mediated reductive radical addition between
difluorobenzyl chloride 7a and styrene (13) realized further
C−C bond formation through difluorobenzyl radical III
(Figure 4B). Indeed, treatment of 7a and 13 with samarium
iodide in the presence of HMPA and TMEDA in methanol
afforded difluoromethylene 14 in good yield without C−F
cleavage or damage to the bromo group.8d Thus, the significant
versatility of difluorobenzyl chlorides allowed us to synthesize a
wide range of organofluorines by not only substitution
reactions but also radical reactions.
In summary, we have developed an efficient method for the
synthesis of α,α-difluorobenzyl chlorides through single C−F
chlorination of benzotrifluorides with trityl chloride assisted by
an o-hydrosilyl group. Equilibrium generation of trityl cation
and chloride anion from trityl chloride facilitated the efficient
C−F chlorination leaving the difluoromethylene group intact,
whereas it is not easy to prepare difluoromethylenes by
previously reported defluorohalogenation methods.10 The
good transformabilities of the chloro and fluorosilyl groups
realized the synthesis of diverse difluorobenzyl ethers having a
transformable o-bromo group. Further studies to expand
synthesizable organofluorines involving the development of
synthetic methods for o-hydrosilyl-substituted benzotrifluor-
ides are ongoing in our group.
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
The authors thank Dr. Yuki Sakata at Tokyo Medical and
Dental University for HRMS analyses. This work was
supported by JSPS KAKENHI Grants JP19K05451 (C;
S.Y.), JP18H02104 (B; T.H.), and JP18H04386 (Middle
Molecular Strategy; T.H.); the Naito Foundation (S.Y.); the
Japan Agency for Medical Research and Development
(AMED) under Grant JP20am0101098 (Platform Project for
Supporting Drug Discovery and Life Science Research,
BINDS); the Cooperative Research Project of the Research
Center for Biomedical Engineering; and the Research Program
of “Five-Star Alliance” in “Network Joint Research Center for
Materials and Devices”. HRMS analyses were performed using
research equipment shared in MEXT Project for Promoting
Public Utilization of Advanced Research Infrastructure
(Program for Supporting Introduction of the New Sharing
System), Grant JPMXS0422300120.
REFERENCES
■
(1) (a) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V.
(b) Gillis, E. P.; Eastman, K. J.; Hill, M. D.; Donnelly, D. J.; Meanwell,
2015, 58, 8315.
ASSOCIATED CONTENT
■
(2) Hiyama, T.; Yamamoto, H. Organofluorine Building Blocks. In
Organofluorine Compounds; Yamamoto, H., Ed.; Springer: Berlin,
2000; pp 77−118.
(3) For recent selected examples of difluoromethylene synthesis, see:
24, 17932. (b) Komoda, K.; Iwamoto, R.; Kasumi, M.; Amii, H.
sı
* Supporting Information
The Supporting Information is available free of charge at
Experimental procedures and characterization data for
new compounds, including NMR spectra (PDF)
D
Org. Lett. XXXX, XXX, XXX−XXX